PMID- 36305946
OWN - NLM
STAT- MEDLINE
DCOM- 20230202
LR  - 20230506
IS  - 1432-1335 (Electronic)
IS  - 0171-5216 (Linking)
VI  - 149
IP  - 1
DP  - 2023 Jan
TI  - Long non-coding RNAs involved in retinoblastoma.
PG  - 401-421
LID - 10.1007/s00432-022-04398-z [doi]
AB  - INTRODUCTION: Retinoblastoma (RB) is the most common childhood tumor that can 
      occur in the retina and develop in a sporadic or heritable form. Although various 
      traditional treatment options have been used for patients with RB, identifying 
      novel strategies for childhood cancers is necessary. MATERIAL AND METHODS: 
      Recently, molecular-based targeted therapies have opened a greater therapeutic 
      window for RB. Long non-coding RNAs (lncRNAs) presented a potential role as a 
      biomarker for the detection of RB in various stages. CONCLUSION: LncRNAs by 
      targeting several miRNA/transcription factors play critical roles in the 
      stimulation or suppression of RB. In this review, we summarized recent progress 
      on the functions of tumor suppressors or oncogenes lncRNAs in RB.
CI  - (c) 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, 
      part of Springer Nature.
FAU - Nasrolahi, Ava
AU  - Nasrolahi A
AD  - Infectious Ophthalmologic Research Center, Imam Khomeini Hospital Clinical 
      Research Development Unit, Ahvaz Jundishapur University of Medical Sciences, 
      Ahvaz, Iran.
FAU - Azizidoost, Shirin
AU  - Azizidoost S
AD  - Atherosclerosis Research Center, Ahvaz Jundishapur University of Medical 
      Sciences, Ahvaz, Iran.
FAU - Radoszkiewicz, Klaudia
AU  - Radoszkiewicz K
AD  - Translational Platform for Regenerative Medicine, Mossakowski Medical Research 
      Institute, Polish Academy of Sciences, Warsaw, Poland.
FAU - Najafi, Sajad
AU  - Najafi S
AD  - Department of Medical Biotechnology, School of Advanced Technologies in Medicine, 
      Shahid Beheshti University of Medical Sciences, Tehran, Iran.
FAU - Ghaedrahmati, Farhoodeh
AU  - Ghaedrahmati F
AD  - Department of Immunology, School of Medicine, Isfahan University of Medical 
      Sciences, Isfahan, Iran.
FAU - Sheykhi-Sabzehpoush, Mohadeseh
AU  - Sheykhi-Sabzehpoush M
AD  - Department of Immunology, School of Medicine, Ahvaz Jundishapur University of 
      Medical Sciences, Ahvaz, Iran.
FAU - Poodineh, Jafar
AU  - Poodineh J
AD  - Department of Clinical Biochemistry, School of Medicine, Zabol University of 
      Medical Sciences, Zabol, Iran.
FAU - Hajizadeh, Maryam
AU  - Hajizadeh M
AD  - Infectious Ophthalmologic Research Center, Imam Khomeini Hospital Clinical 
      Research Development Unit, Ahvaz Jundishapur University of Medical Sciences, 
      Ahvaz, Iran.
AD  - Department of Ophthalmology, Imam Khomeini Hospital, School of Medicine, Ahvaz 
      Jundishapur University of Medical Sciences, Ahvaz, Iran.
FAU - Anbiyaiee, Amir
AU  - Anbiyaiee A
AD  - Department of Surgery, School of Medicine, Ahvaz Jundishapur University of 
      Medical Sciences, Ahvaz, Iran.
FAU - Farzaneh, Maryam
AU  - Farzaneh M
AD  - Fertility, Infertility and Perinatology Research Center, Ahvaz Jundishapur 
      University of Medical Sciences, Ahvaz, Iran. farzaneh-m@ajums.ac.ir.
FAU - Feghhi, Mostafa
AU  - Feghhi M
AD  - Infectious Ophthalmologic Research Center, Imam Khomeini Hospital Clinical 
      Research Development Unit, Ahvaz Jundishapur University of Medical Sciences, 
      Ahvaz, Iran. mfeghhi@ajums.ac.ir.
AD  - Department of Ophthalmology, Imam Khomeini Hospital, School of Medicine, Ahvaz 
      Jundishapur University of Medical Sciences, Ahvaz, Iran. mfeghhi@ajums.ac.ir.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20221028
PL  - Germany
TA  - J Cancer Res Clin Oncol
JT  - Journal of cancer research and clinical oncology
JID - 7902060
RN  - 0 (RNA, Long Noncoding)
RN  - 0 (MicroRNAs)
RN  - 0 (Biomarkers)
SB  - IM
MH  - Humans
MH  - Child
MH  - *Retinoblastoma/genetics/pathology
MH  - *RNA, Long Noncoding/genetics
MH  - *MicroRNAs/genetics
MH  - Biomarkers
MH  - *Retinal Neoplasms/genetics/pathology
OTO - NOTNLM
OT  - Biomarker
OT  - Long non-coding RNA
OT  - Oncogene
OT  - Retinoblastoma
OT  - Tumor suppressor
EDAT- 2022/10/29 06:00
MHDA- 2023/02/03 06:00
CRDT- 2022/10/28 11:24
PHST- 2022/09/12 00:00 [received]
PHST- 2022/10/05 00:00 [accepted]
PHST- 2022/10/29 06:00 [pubmed]
PHST- 2023/02/03 06:00 [medline]
PHST- 2022/10/28 11:24 [entrez]
AID - 10.1007/s00432-022-04398-z [pii]
AID - 10.1007/s00432-022-04398-z [doi]
PST - ppublish
SO  - J Cancer Res Clin Oncol. 2023 Jan;149(1):401-421. doi: 
      10.1007/s00432-022-04398-z. Epub 2022 Oct 28.